Biomedical implants are the need of this era due to the increase in number of accidents and follow-up surgeries. Different types of bone diseases such as osteoarthritis, osteomalacia, bone cancer, etc., are increasing globally. Mesoporous bioactive glass nanoparticles (MBGNs) are used in biomedical devices due to their osteointegration and bioactive properties. In this study, silver (Ag)- and strontium (Sr)-doped mesoporous bioactive glass nanoparticles (Ag-Sr MBGNs) were prepared by a modified Stöber process. In this method, Ag+ and Sr2+ were co-substituted in pure MBGNs to harvest the antibacterial properties of Ag ions, as well as pro-osteogenic potential of Sr2 ions. The effect of the two-ion concentration on morphology, surface charge, composition, antibacterial ability, and in-vitro bioactivity was studied. Scanning electron microscopy (SEM), X-Ray diffraction (XRD), and Fourier transform infrared spectroscopy (FTIR) confirmed the doping of Sr and Ag in MBGNs. SEM and EDX analysis confirmed the spherical morphology and typical composition of MBGNs, respectively. The Ag-Sr MBGNs showed a strong antibacterial effect against Staphylococcus carnosus and Escherichia coli bacteria determined via turbidity and disc diffusion method. Moreover, the synthesized Ag-Sr MBGNs develop apatite-like crystals upon immersion in simulated body fluid (SBF), which suggested that the addition of Sr improved in vitro bioactivity. The Ag-Sr MBGNs synthesized in this study can be used for the preparation of scaffolds or as a filler material in the composite coatings for bone tissue engineering.

This review focuses on the therapeutic effects of ions when released in physiological environments. Recent studies have shown that metallic ions like Ag+, Sr2+, Mg2+, Mn2+, Cu2+, Ca2+, P+5, etc., have shown promising results in drug delivery systems and regenerative medicine. These metallic ions can be loaded in nanoparticles, mesoporous bioactive glass nanoparticles (MBGNs), hydroxyapatite (HA), calcium phosphates, polymeric coatings, and salt solutions. The metallic ions can exhibit different functions in the physiological environment such as antibacterial, antiviral, anticancer, bioactive, biocompatible, and angiogenic effects. Furthermore, the metals/metalloid ions can be loaded into scaffolds to improve osteoblast proliferation, differentiation, bone development, fibroblast growth, and improved wound healing efficacy. Moreover, different ions possess different therapeutic limits. Therefore, further mechanisms need to be developed for the highly controlled and sustained release of these ions. This review paper summarizes the recent progress in the use of metallic/metalloid ions in regenerative medicine and encourages further study of ions as a solution to cure diseases.

Biomedical implants are the need of this era due to the increase in number of accidents and follow-up surgeries. Different types of bone diseases such as osteoarthritis, osteomalacia, bone cancer, etc. are increasing globally. Mesoporous bioactive glass nanoparticles (MBGNs) are used in biomedical devices due to their osteointegration and bioactive properties. In this study, silver (Ag) and strontium (Sr) doped mesoporous bioactive glass nanoparticles (Ag-Sr MBGNs) were prepared by a modified Stöber process. In this method, Ag+ & Sr2+ were co-substituted in pure MBGNs to harvest the antibacterial properties of Ag ions, as well as pro-osteogenic potential of Sr2 ions. The effect of the two ion concentration on morphology, surface charge, composition, antibacterial ability, and in-vitro bioactivity was studied. Scanning electron microscopy (SEM), X-Ray diffraction (XRD) and Fourier transform infrared spectroscopy (FTIR) confirmed the doping of Sr and Ag in MBGNs. SEM and EDX analysis confirmed the spherical morphology and typical composition of MBGNs, respectively. The Ag-Sr MBGNs showed a strong antibacterial effect against Staphylococcus carnosus and Escherichia coli bacteria determined via turbidity and disc diffusion method. Moreover, the synthesized Ag-Sr MBGNs develop apatite-like crystals upon immersion in simulated body fluid (SBF), which suggested that the addition of Sr improved in-vitro bioactivity. The Ag-Sr MBGNs synthesize in this study can be used for the preparation of scaffolds or as a filler material in the composite coatings for bone tissue engineering.

No abstract

Bioceramic coatings on metallic implants provide a wear-resistant and biocompatible layer, that own ability to develop bone-like apatite in physiological environments to ensure bonding with hard tissues. These bioceramics primarily belong to Calcium Phosphates (CaPs), bioactive glasses, and glass-ceramics. Several techniques are used to deposit these coatings such as; electrophoretic deposition (EPD), plasma spray (PS), and Radio frequency magnetron sputtering (RFMS). Most of these techniques require a high-temperature operation or sintering treatment. This causes either thermal decomposition of bioceramic or results in delamination and cracking of the bioceramic coating due to differences in thermal expansion behavior of metals and bioceramics. RFMS is primarily carried out either at room temperature. However, annealing is performed or substrate is heated at various temperatures ∼400–1,200°C for 2 or 4 h under dry argon (very low temperature compared to other techniques) to ensure crystallization of bioceramics and improve coating adhesion. Chemical composition stability and excellent surface finish are the premium features of RFMS, due to less heat involvement. Moreover, RFMS has the unique ability to develop one-unit/ multilayered composite coatings and the flexibility of in-situ reactions to yield oxides and nitrides. Single or multiple targets can be employed with the insertion of Oxygen and Nitrogen to yield versatile coatings. Due to this attractive set of features RFMS has a strong potential in the field of bioceramic coatings. In recent years, several multifunctional bioceramic coatings have been deposited on metallic substrates using RFMS for biomedical applications. This review focuses on the recent efforts made in order to deposit multifunctional bioceramic RFMS coatings with surface characteristics necessary for biomedical applications and highlights future directions for the improved biological performance of RFMS bioceramic coatings.

There is an urgent need to develop biodegradable implants that can degrade once they have fulfilled their function. Commercially pure magnesium (Mg) and its alloys have the potential to surpass traditional orthopedic implants due to their good biocompatibility and mechanical properties, and most critically, biodegradability. The present work focuses on the synthesis and characterization (microstructural, antibacterial, surface, and biological properties) of poly(lactic-co-glycolic) acid (PLGA)/henna (Lawsonia inermis)/Cu-doped mesoporous bioactive glass nanoparticles (Cu-MBGNs) composite coatings deposited via electrophoretic deposition (EPD) on Mg substrates. PLGA/henna/Cu-MBGNs composite coatings were robustly deposited on Mg substrates using EPD, and their adhesive strength, bioactivity, antibacterial activity, corrosion resistance, and biodegradability were thoroughly investigated. Scanning electron microscopy and Fourier transform infrared spectroscopy studies confirmed the uniformity of the coatings’ morphology and the presence of functional groups that were attributable to PLGA, henna, and Cu-MBGNs, respectively. The composites exhibited good hydrophilicity with an average roughness of 2.6 μm, indicating desirable properties for bone forming cell attachment, proliferation, and growth. Crosshatch and bend tests confirmed that the adhesion of the coatings to Mg substrates and their deformability were adequate. Electrochemical Tafel polarization tests revealed that the composite coating adjusted the degradation rate of Mg substrate in a human physiological environment. Incorporating henna into PLGA/Cu-MBGNs composite coatings resulted in antibacterial activity against Escherichia coli and Staphylococcus aureus. The coatings stimulated the proliferation and growth of osteosarcoma MG-63 cells during the initial incubation period of 48 h (determined by the WST-8 assay).

No abstract

No abstract